Taiwan FDA registration 06e7c7e0a8f9962a94f0a509d110841f
Pson breast cancer antigen 15-3 enzyme immunoassay group
TW: 普生乳癌抗原15-3 酵素免疫分析組
Taiwan·Risk Class 2·BIOCHECK, INC.·Registered Dec 13, 2006 – Dec 13, 2016CancelledRegistration details
- Analysis ID
- 06e7c7e0a8f9962a94f0a509d110841f
- Customs Code
- DHA00601783105
Company information
- Manufacturer
- BIOCHECK, INC.
- Manufacturer Country
- United States
- Authorized Representative
- GENERAL BIOLOGICALS CORP.
Product details
- Intended Use
- It is used for the quantitative analysis of serum turbidity of tumor antigen CA15-3.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.6010 腫瘤相關抗原免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Dec 13, 2006
- Expiry Date
- Dec 13, 2016
- Cancellation Date
- Jun 28, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Pson breast cancer antigen 15-3 enzyme immunoassay group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 06e7c7e0a8f9962a94f0a509d110841f and manufactured by BIOCHECK, INC.. The authorized representative in Taiwan is GENERAL BIOLOGICALS CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices